Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Not all wealth building strategies are created equal. Discover the ones that truly work and can help you grow your finances effectively.
17,941 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
As the world watches the Strait of Hormuz, Canada’s Pacific energy links rise in importance. Kitimat LNG and the Tran...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
A $130,000 insider sale at CorVel raises questions for investors. This guide breaks down what the move could mean, ho...
PayPal reports a solid quarter but the stock falls as the company commits to an AI-driven reorganization. The legacy ...
A top economist says wage gains aren’t keeping up with inflation, leaving Americans literally getting squeezed as hou...
A famous endorsement pulled ordinary investors into a wild crypto ride, ending in legal battles and hard lessons. Thi...
Mortgage rates have climbed to yearly highs as the 10-year yield advances, but housing demand remains positive due to...
Nu Holdings signals growing resilience as it posts a record Q1. This deep dive explains what the results mean for NU ...
In 2022, the S&P 500 tumbled as inflation hung over markets, but healthcare ETFs held up better. This piece examines ...